Oct. 15 at 2:25 PM
$LH earnings preview: Will organic growth and acquisitions drive another beat? 🚀
Labcorp's Dx segment is forecasted to see an 8.4% revenue boost, while BLS could rise 7.5%, aided by Central Laboratories' performance and digital pathology capabilities. However, a negative Earnings ESP of -0.17% could be a hurdle.
Find out if Labcorp can continue its streak here 👉 https://www.zacks.com/stock/news/2769002/labcorp-gears-up-to-report-q3-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2769002-body-16152&ADID=SYND_STOCKTWITS_TWEET_2_2769002_BODY_16152